These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35890416)

  • 41. Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers.
    Fattahi MR; Dehghani M; Paknahad S; Rahiminia S; Zareie D; Hoseini B; Oroomi TR; Motedayyen H; Arefnezhad R
    Front Oncol; 2024; 14():1438297. PubMed ID: 39193389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The future of plant based green carbon dots as cancer Nanomedicine: From current progress to future Perspectives and beyond.
    Jing HH; Shati AA; Alfaifi MY; Elbehairi SEI; Sasidharan S
    J Adv Res; 2024 Feb; ():. PubMed ID: 38320729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carrier-Free Nanomedicine for Cancer Immunotherapy.
    Fu Y; Bian X; Li P; Huang Y; Li C
    J Biomed Nanotechnol; 2022 Apr; 18(4):939-956. PubMed ID: 35854464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
    Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
    World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy.
    Zhu R; He Q; Li Z; Ren Y; Liao Y; Zhang Z; Dai Q; Wan C; Long S; Kong L; Fan W; Yu W
    Acta Biomater; 2022 Nov; 153():442-452. PubMed ID: 36179978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanomedicine and versatile therapies for cancer treatment.
    Shukla A; Maiti P
    MedComm (2020); 2022 Sep; 3(3):e163. PubMed ID: 35992969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.
    Yang G; Cao Y; Yang X; Cui T; Tan NZV; Lim YK; Fu Y; Cao X; Bhandari A; Enikeev M; Efetov S; Balaban V; He M
    Exp Mol Pathol; 2024 Jun; 137():104904. PubMed ID: 38788248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanomedicine for Combination Urologic Cancer Immunotherapy.
    Tian Y; Liu Z; Wang J; Li L; Wang F; Zhu Z; Wang X
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
    Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanomedicine in treatment of breast cancer - A challenge to conventional therapy.
    Afzal M; Ameeduzzafar ; Alharbi KS; Alruwaili NK; Al-Abassi FA; Al-Malki AAL; Kazmi I; Kumar V; Kamal MA; Nadeem MS; Aslam M; Anwar F
    Semin Cancer Biol; 2021 Feb; 69():279-292. PubMed ID: 31870940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcellular-Targeted Near-Infrared-Responsive Nanomedicine with Synergistic Chemo-photothermal Therapy against Multidrug Resistant Cancer.
    Tang Z; Tian W; Long H; Jiang S; Zhao J; Zhou J; He Q; Luo X
    Mol Pharm; 2022 Dec; 19(12):4538-4551. PubMed ID: 35311257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy.
    He M; Cao Y; Chi C; Zhao J; Chong E; Chin KXC; Tan NZV; Dmitry K; Yang G; Yang X; Hu K; Enikeev M
    Front Immunol; 2023; 14():1265751. PubMed ID: 37795091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multifunctional Cargo-Free Nanomedicine for Cancer Therapy.
    Wang Y; Yang P; Zhao X; Gao D; Sun N; Tian Z; Ma T; Yang Z
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
    Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
    Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
    Kemp JA; Shim MS; Heo CY; Kwon YJ
    Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced nanomedicines for the regulation of cancer metabolism.
    Yang J; Zhao Y; Zhou Y; Wei X; Wang H; Si N; Yang J; Zhao Q; Bian B; Zhao H
    Biomaterials; 2022 Jul; 286():121565. PubMed ID: 35576808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanoparticles for Effective Combination Therapy of Cancer.
    Jadia R; Scandore C; Rai P
    Int J Nanotechnol Nanomed; 2016; 1(1):. PubMed ID: 28540369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.